SCHEMBL24845161

SCHEMBL24845161

COc1ncccc1-c1cccc2nc(NC(=O)c3cccc(C(=O)O)c3)n(CCCCCN)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K7 O43318 1/20 0.41
EGFR P00533 1/20 0.41
EHMT2 Q96KQ7 2/20 0.40
EHMT1 Q9H9B1 1/20 0.40
ITK Q08881 2/20 0.40
IRAK4 Q9NWZ3 5/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
TSHR P16473 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.40
STING1 Q86WV6 3/20 0.40
ADORA2A P29274 2/20 0.40
OPRK1 P41145 1/20 0.40
CLK2 P49760 1/20 0.38
CDK9 P50750 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30163826 1.00 MAP3K7 (0.41) MAP3K7EGFREHMT2EHMT1ITK
SCHEMBL24845818 0.82 OPRK1 (0.47) MAP3K7EHMT2EHMT1ITKIRAK4
SCHEMBL29154814 0.81 EHMT2 (0.48) MAP3K7EHMT2EHMT1ITKIRAK4
SCHEMBL30163798 0.81 EHMT2 (0.48) MAP3K7EHMT2EHMT1ITKIRAK4
SCHEMBL30163713 0.81 STING1 (0.55) EGFRIRAK4STING1ADORA2AOPRK1
SCHEMBL24845162 0.81 STING1 (0.55) EGFRIRAK4STING1ADORA2AOPRK1
SCHEMBL24845491 0.77 MAP3K7 (0.64) MAP3K7EHMT2EHMT1ITKIRAK4
SCHEMBL24845520 0.77 MAP3K7 (0.64) MAP3K7EHMT2EHMT1ITKIRAK4
SCHEMBL30163791 0.77 MAP3K7 (0.64) MAP3K7EHMT2EHMT1ITKIRAK4
SCHEMBL30163769 0.77 MAP3K7 (0.64) MAP3K7EHMT2EHMT1ITKIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117561262-A Macrocyclic TAK1 inhibitors 阿奎利恩有限公司 2024-02-13 CN disclosed
WO-2023275199-A1 MACROCYCLIC TAK1 INHIBITORS AQILION AB (SE) 2023-01-05 WO disclosed